Mitochondrial Nutrition and Cellular Repair: A New Path for Cognitive Health in Alzheimer’s and MCI
Read the full publication here.
Memory loss and cognitive decline aren’t just common signs of aging — for many people, they may be early indicators of Mild Cognitive Impairment (MCI) or even Alzheimer’s disease (AD). In recent years, researchers and health professionals have been exploring alternative strategies beyond traditional pharmaceuticals. Among these, personalized nutrition and non-invasive cellular support technologies have started to gain momentum.
A study published in the Journal of Clinical Trials took a closer look at this combined approach: a personalized mitochondrial food plan alongside a therapy called NanoVi™, aimed at improving cognitive performance and quality of life in patients with MCI and Alzheimer’s.
What Is the “Mito Food Plan”?
The Mito Food Plan is a dietary strategy designed to support mitochondrial health — the mitochondria being the energy-producing powerhouses of our cells. Since the brain is one of the body’s most energy-demanding organs, supporting its energy metabolism can have direct effects on mental clarity, memory, and overall function.
Each participant in the study received a customized version of this food plan tailored to their needs and metabolic profile.
What Is NanoVi™ Cellular Repair Therapy?
NanoVi™ is a non-invasive technology that emits a specific signal to assist in the repair of oxidative damage to proteins, mimicking a natural biological process that tends to decline with age. Importantly, this signal does not produce harmful reactive oxygen species (ROS) — instead, it supports the body’s own ability to recover from oxidative stress and maintain cellular health.
In the study, participants received 30-minute NanoVi™ sessions three times per week over a 12-week period.
Promising Results
The outcomes were encouraging: 80% of participants showed significant improvements in cognitive test scores. Quality of life also improved, and markers of cellular health — such as phase angle, an indicator of cell membrane integrity — showed a positive trend.
Interestingly, the one participant who showed cognitive decline had poor compliance with both the dietary plan and therapy sessions. This highlights the importance of consistency when implementing lifestyle-based interventions.
What Can We Learn from This?
While the study had a small sample size and lacked a control group — meaning the results should be interpreted with caution — it still offers valuable insight: Integrative interventions, when applied consistently and tailored to the individual, may offer real cognitive benefits.
Targeting mitochondrial function through personalized nutrition and supporting the body’s cellular repair mechanisms may represent a powerful new direction in the care of individuals with early-stage cognitive decline.
Reference: Hank NC, Pereira J, McCravey B, Christians L, Hoggan C, Dechoux F. Cognitive Improvements in Patients with Mild Cognitive Impairment and Alzheimer’s Disease through a Personalized Mito Food Plan Diet and Cell Repair Therapy. Journal of Clinical Trials. 2018; 8(5).
